Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 539

1.

Antimicrobial Chemotherapy.

Neu HC, Gootz TD.

In: Baron S, editor. Medical Microbiology. 4th edition. Galveston (TX): University of Texas Medical Branch at Galveston; 1996. Chapter 11.

2.

National epidemiology of mycoses survey: a multicenter study of strain variation and antifungal susceptibility among isolates of Candida species.

Pfaller MA, Messer SA, Houston A, Rangel-Frausto MS, Wiblin T, Blumberg HM, Edwards JE, Jarvis W, Martin MA, Neu HC, Saiman L, Patterson JE, Dibb JC, Roldan CM, Rinaldi MG, Wenzel RP.

Diagn Microbiol Infect Dis. 1998 May;31(1):289-96.

PMID:
9597389
3.

Reduction in tuberculin skin-test conversions among medical house staff associated with improved tuberculosis infection control practices.

Bangsberg DR, Crowley K, Moss A, Dobkin JF, McGregor C, Neu HC.

Infect Control Hosp Epidemiol. 1997 Aug;18(8):566-70.

PMID:
9276238
4.

Antibiotic susceptibility of multiply resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis, including candidates for transplantation.

Saiman L, Mehar F, Niu WW, Neu HC, Shaw KJ, Miller G, Prince A.

Clin Infect Dis. 1996 Sep;23(3):532-7.

PMID:
8879776
5.

Safety of cefepime: a new extended-spectrum parenteral cephalosporin.

Neu HC.

Am J Med. 1996 Jun 24;100(6A):68S-75S.

PMID:
8678100
6.
7.

Postantibiotic effect of ceftibuten on respiratory pathogens.

Chin NX, Huang HB, Neu HC.

Pediatr Infect Dis J. 1995 Jul;14(7 Suppl):S84-7.

PMID:
7567315
8.

Emergence and mechanisms of bacterial resistance in surgical infections.

Neu HC.

Am J Surg. 1995 May;169(5A Suppl):13S-20S. Review.

PMID:
7755162
9.
10.

In vitro activity of the new fluoroquinolone CP-99,219.

Neu HC, Chin NX.

Antimicrob Agents Chemother. 1994 Nov;38(11):2615-22.

11.

Cytologically proven seronegative Lyme choroiditis and vitritis.

Schubert HD, Greenebaum E, Neu HC.

Retina. 1994;14(1):39-42.

PMID:
8016460
12.

Major advances in antibacterial quinolone therapy.

Neu HC.

Adv Pharmacol. 1994;29A:227-62. Review. No abstract available.

PMID:
7826861
13.

Emerging trends in antimicrobial resistance in surgical infections. A review.

Neu HC.

Eur J Surg Suppl. 1994;(573):7-18. Review.

PMID:
7524800
15.

Elimination of Staphylococcus aureus nasal carriage in health care workers: analysis of six clinical trials with calcium mupirocin ointment. The Mupirocin Collaborative Study Group.

Doebbeling BN, Breneman DL, Neu HC, Aly R, Yangco BG, Holley HP Jr, Marsh RJ, Pfaller MA, McGowan JE Jr, Scully BE, et al.

Clin Infect Dis. 1993 Sep;17(3):466-74.

PMID:
8218691
16.

Probenecid-resistant J774 cell expression of enhanced organic anion transport by a mechanism distinct from multidrug resistance.

Cao C, Steinberg TH, Neu HC, Cohen D, Horwitz SB, Hickman S, Silverstein SC.

Infect Agents Dis. 1993 Aug;2(4):193-200.

PMID:
7909709
17.

Amoxycillin/clavulanic acid: a review of its efficacy in over 38,500 patients from 1979 to 1992.

Neu HC, Wilson AP, Gr√ľneberg RN.

J Chemother. 1993 Apr;5(2):67-93. Review.

PMID:
8515298
18.

In vitro activity of fleroxacin in combination with other antimicrobial agents.

Neu HC, Chin NX.

Am J Med. 1993 Mar 22;94(3A):9S-16S. Review.

PMID:
8452190
19.

In vitro activity and beta-lactamase stability of FK-037, a parenteral cephalosporin.

Neu HC, Chin NX, Huang HB.

Antimicrob Agents Chemother. 1993 Mar;37(3):566-73.

20.

Infection problems for the 1990's--do we have an answer?

Neu HC.

Scand J Infect Dis Suppl. 1993;91:7-13.

PMID:
8290904
21.
22.

Gemfibrozil enhances the listeriacidal effects of fluoroquinolone antibiotics in J774 macrophages.

Rudin DE, Gao PX, Cao CX, Neu HC, Silverstein SC.

J Exp Med. 1992 Nov 1;176(5):1439-47.

23.
24.

In vitro activity of CP-74,667. A new fluoroquinolone compared with other quinolones.

Gu JW, Fang W, Chin NX, Neu HC.

Diagn Microbiol Infect Dis. 1992 Sep-Oct;15(7):613-20.

PMID:
1330421
25.

The crisis in antibiotic resistance.

Neu HC.

Science. 1992 Aug 21;257(5073):1064-73. Review.

PMID:
1509257
26.

Can fluoroquinolones be considered once-daily therapy?

Neu HC.

J Clin Pharmacol. 1992 Aug;32(8):692-7. Review.

PMID:
1487557
27.

Once-daily oral antimicrobial therapy: is a consensus possible?

Neu HC.

J Clin Pharmacol. 1992 Aug;32(8):685. No abstract available.

PMID:
1487555
28.

In vitro antimicrobial activity of the new antibiotic vermisporin.

Chin NX, Neu HC.

Eur J Clin Microbiol Infect Dis. 1992 Aug;11(8):755-7.

PMID:
1425739
29.

The activity of metal compounds against aerobic and anaerobic bacteria.

Chin N, Neu HC.

Diagn Microbiol Infect Dis. 1992 Aug;15(6):549-52.

PMID:
1424509
30.

In vitro activity of MC-352, a new 16-membered macrolide.

Chin NX, Neu HC.

Antimicrob Agents Chemother. 1992 Aug;36(8):1699-702.

31.

In vitro activity and beta-lactamase stability of LJC 10,627.

Neu HC, Gu JW, Fang W, Chin NX.

Antimicrob Agents Chemother. 1992 Jul;36(7):1418-23.

32.

Comparative in vitro activity and beta-lactamase stability of RU29246, the active metabolite of HR916B.

Yu KW, Chin NX, Neu HC.

Eur J Clin Microbiol Infect Dis. 1992 Jul;11(7):652-9.

PMID:
1396779
33.

Post-antibiotic effect of the new streptogramin RP 59500.

Chin NX, Neu HC.

Eur J Clin Microbiol Infect Dis. 1992 Jul;11(7):642-5.

PMID:
1396777
34.

The in-vitro activity of new streptogramins, RP 59500, RP 57669 and RP 54476, alone and in combination.

Neu HC, Chin NX, Gu JW.

J Antimicrob Chemother. 1992 Jul;30 Suppl A:83-94.

PMID:
1328138
35.

In vitro activity and susceptibility to hydrolysis of S-1006.

Neu HC, Gu JW, Fang W, Chin NX.

Antimicrob Agents Chemother. 1992 Jun;36(6):1336-41.

36.

In vitro activity of OPC-17116.

Neu HC, Fang W, Gu JW, Chin NX.

Antimicrob Agents Chemother. 1992 Jun;36(6):1310-5.

37.

In vitro activity of cefquinome, a new cephalosporin, compared with other cephalosporin antibiotics.

Chin NX, Gu JW, Fang W, Neu HC.

Diagn Microbiol Infect Dis. 1992 May-Jun;15(4):331-7.

PMID:
1611848
38.

In vitro activity of the new glycopeptide decaplanin.

Neu HC, Chin NX, Niu WW.

Eur J Clin Microbiol Infect Dis. 1992 May;11(5):458-62.

PMID:
1330562
39.

Urinary tract infections.

Neu HC.

Am J Med. 1992 Apr 6;92(4A):63S-70S. Review.

PMID:
1580271
41.

Use of antimicrobial agents to treat central nervous system infection.

Klein O, Neu HC.

Neurosurg Clin N Am. 1992 Apr;3(2):323-42. Review.

PMID:
1633463
42.

New macrolide antibiotics: azithromycin and clarithromycin.

Neu HC.

Ann Intern Med. 1992 Mar 15;116(6):517-9. No abstract available.

PMID:
1310839
43.

Antibiotic resistance. Epidemiology and therapeutics.

Neu HC, Duma RJ, Jones RN, McGowan JE Jr, O'Brien TF, Sabath LD, Sanders CC, Schaffner W, Tally FP, Tenover FC, et al.

Diagn Microbiol Infect Dis. 1992 Feb;15(2 Suppl):53S-60S. No abstract available.

PMID:
1737445
44.

Therapeutic and epidemiologic recommendations to reduce the spread of type-I beta-lactamase resistance.

Neu HC, Duma RJ, Jones RN, McGowan JE Jr, O'Brien TF, Sabath LD, Sanders CC, Schaffner W, Tenover FC, Young LS.

Diagn Microbiol Infect Dis. 1992 Feb;15(2 Suppl):49S-52S. Review.

PMID:
1737444
45.

Mupirocin treatment of nasal staphylococcal colonization.

Scully BE, Briones F, Gu JW, Neu HC.

Arch Intern Med. 1992 Feb;152(2):353-6.

PMID:
1739366
46.

J774 macrophages secrete antibiotics via organic anion transporters.

Cao CX, Silverstein SC, Neu HC, Steinberg TH.

J Infect Dis. 1992 Feb;165(2):322-8.

PMID:
1730899
47.

Microbiology of bacterial meningitis pathogens.

Neu HC.

Antibiot Chemother (1971). 1992;45:52-67. Review. No abstract available.

PMID:
1610141
48.

Quinolone antimicrobial agents.

Neu HC.

Annu Rev Med. 1992;43:465-86. Review.

PMID:
1580602
49.

Resistance of Pseudomonas aeruginosa to imipenem.

Neu HC.

Infect Control Hosp Epidemiol. 1992 Jan;13(1):7-9. No abstract available.

PMID:
1545114
50.

Supplemental Content

Support Center